Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             76 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2013
 45 S3 p. S261-S262
2 p.
 artikel
2 Editorial Board 2013
 45 S3 p. i-
1 p.
 artikel
3 FRI-12 Intraarterial therapies or surgery Pawlik, T.
 2013
 45 S3 p. S245-
1 p.
 artikel
4 FRI-11 Intra-arterial therapies: SIRT or TACE? de Baère, T.
 2013
 45 S3 p. S245-
1 p.
 artikel
5 FRI-03 Intraarterial therapies: SIRT or TACE Pereira, P.L.
 2013
 45 S3 p. S241-S242
2 p.
 artikel
6 FRI-08 Is there a role for interventional therapies in localized breast cancer? Pfleiderer, S.
 2013
 45 S3 p. S244-
1 p.
 artikel
7 FRI-02 Liver metastases from melanoma Adam, R.
 2013
 45 S3 p. S240-S241
2 p.
 artikel
8 FRI-04 Modern systemic drug therapies in 2013 Garbe, C.
 2013
 45 S3 p. S242-
1 p.
 artikel
9 FRI-07 Modern systemic drug therapies in breast cancer in 2013 Zielinski, C.C.
 2013
 45 S3 p. S244-
1 p.
 artikel
10 FRI-14 Modern systemic therapy of neuroendocrine tumors in 2013 Öberg, K.
 2013
 45 S3 p. S246-
1 p.
 artikel
11 FRI-13 Molecular imaging (Gallium-68 SMS-receptor PET/CT) and peptide receptor radionuclide therapy (PRRNT) of GEP-neuroendocrine neoplasms (GEP-NEP) Baum, R.P.
 2013
 45 S3 p. S246-
1 p.
 artikel
12 FRI-09 Neuroendocrine tumors of the GI-tract Tannapfel, A.
 2013
 45 S3 p. S244-S245
2 p.
 artikel
13 FRI-05 Palliative surgery in liver metastases from breast cancer: Is there evidence? An overview Bergenfeldt, M.
 2013
 45 S3 p. S242-S243
2 p.
 artikel
14 FRI-10 Surgical treatment of hepatic metastases from neuroendocrine tumors (NEN) Goretzki, P.E.
 2013
 45 S3 p. S245-
1 p.
 artikel
15 FRI-01 The four melanomas Keilholz, U.
 2013
 45 S3 p. S240-
1 p.
 artikel
16 FRI-06 Transarterial chemoembolization and radioembolization in the treatment of liver tumors Coldwell, D.M.
 2013
 45 S3 p. S244-
1 p.
 artikel
17 OP-15 A Phase I evaluation of transcatheter arterial chemoembolization with doxorubicin-loaded LC beads (DEBDOX) in the treatment of liver metastases: A multicenter feasibility trial Martin, R.C.G.
 2013
 45 S3 p. S253-
1 p.
 artikel
18 OP-24 Application of three-dimensional imaging on an iPad during liver surgery Kuhlmann, K.F.D.
 2013
 45 S3 p. S256-S257
2 p.
 artikel
19 OP-32 Bipolar radiofrequency ablation for symptomatic giant (>10 cm) hepatic cavernous haemangiomas: Initial clinical experience Scheffer, H.J.
 2013
 45 S3 p. S259-
1 p.
 artikel
20 OP-02 Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: A new personalized promising concept Garin, E.
 2013
 45 S3 p. S249-
1 p.
 artikel
21 OP-29 Changes in VEGF-A-serum levels after chemoembolization with irinotecan loaded drug-eluting beads (DEBIRI) in patients with chemo refractory liver metastases of colorectal cancer Dyrda, S.
 2013
 45 S3 p. S258-
1 p.
 artikel
22 OP-16 Chemoembolization adopting drug eluting beads preloaded with irinotecan (DEBIRI) plus cetuximab (debiritux) as second-line treatment for metastatic colorectal cancer (CRC) to the liver: Results of a clinical phase II trial Fiorentini, G.
 2013
 45 S3 p. S253-S254
2 p.
 artikel
23 OP-17 Complete response of liver metastases (LM) from colorectal cancer (CRC) after intra-arterial hepatic chemotherapy (IAHC) of floxuridine (FLO): Outcome and perspectives Fiorentini, G.
 2013
 45 S3 p. S254-
1 p.
 artikel
24 OP-05 Detection and characterization of circulating epithelial tumor cells in liver cancer patients Berger, T.
 2013
 45 S3 p. S250-
1 p.
 artikel
25 OP-19 Evaluation and importance of pathological response of colorectal liver metastases Dede, K.
 2013
 45 S3 p. S254-S255
2 p.
 artikel
26 OP-06 First experiences with superselective TANDEM® TACE in Heidelberg Schmitz, A.
 2013
 45 S3 p. S250-
1 p.
 artikel
27 OP-10 Grifola frondosa water extract induces autophagy and leads to apoptotic cell death through the inhibition of PI3K/AKt and ERK pathways in human Hep3B cancer cells Lin, C.-H.
 2013
 45 S3 p. S251-S252
2 p.
 artikel
28 OP-28 Impact of the surgeon in the multidisciplinary liver-team. Case reports Mersich, T.
 2013
 45 S3 p. S258-
1 p.
 artikel
29 OP-26 Incidence and treatment of local site recurrences following RFA of colorectal liver metastases Nielsen, K.
 2013
 45 S3 p. S257-
1 p.
 artikel
30 OP-07 Initial RECIST tumour reduction as a prognostic parameter for transarterial chemoembolisation treatment success in patients with hepatocellular carcinoma Hasdemir, D.
 2013
 45 S3 p. S251-
1 p.
 artikel
31 OP-04 Initial tumour response after short and long interval chemoembolization with drug-eluting beads (DC-Beads) in hepatocellular carcinoma – A pilot study Syha, R.
 2013
 45 S3 p. S250-
1 p.
 artikel
32 OP-25 Irreversible electroporation for the local treatment of tumors: A new kid on the block. Results of an “ablate and resect” pilot-study of resectable colorectal liver metastases Nielsen, K.
 2013
 45 S3 p. S257-
1 p.
 artikel
33 OP-01 Laparoscopic and percutaneous microwave coagulation therapy of hepatic malignancies: feasibility, efficiency and risk factors for tumor recurrence Eisele, R.M.
 2013
 45 S3 p. S249-
1 p.
 artikel
34 OP-27 Liver resection after selective internal radiotherapy (SIRT) for liver metastasis of colorectal malignancies Justinger, C.
 2013
 45 S3 p. S257-S258
2 p.
 artikel
35 OP-13 Liver resection for cholangiocarcinoma: A single-center experience of the first decade of the new millennium Nickkholgh, A.
 2013
 45 S3 p. S252-S253
2 p.
 artikel
36 OP-30 Liver size remains stable when receiving regeneration and atrophy signals simultaneously: Mathematical model and experimental results Weiwei, W.
 2013
 45 S3 p. S258-S259
2 p.
 artikel
37 OP-23 Management of advanced colorectal carcinoma in a young female patient Macher, A.
 2013
 45 S3 p. S256-
1 p.
 artikel
38 OP-21 Microwave ablation combined with surgical resection as one step treatment for bilateral colorectal liver metastases. A valid alternative strategy in the era of 2-stage treatments Donati, M.
 2013
 45 S3 p. S255-
1 p.
 artikel
39 OP-22 Neoadjuvant chemotherapy allows an increase of resectability in metatsatic liver disease Frena, A.
 2013
 45 S3 p. S255-
1 p.
 artikel
40 OP-09 Pharmacokinetic characteristics of the new treatment combination of sorafenib and resminostat, a novel histone deacetylase (HDAC) inhibitor, in patients with advanced hepatocellular carcinoma (HCC): The SHELTER study Hauns, B.
 2013
 45 S3 p. S251-
1 p.
 artikel
41 OP-14 Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocarcinoma: Optimal tolerance and prolonged overall survival Martin, R.C.G.
 2013
 45 S3 p. S253-
1 p.
 artikel
42 OP-20 Radiological response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI®) for resectable liver metastases from colorectal cancer does not correlate with pathological response or long-term outcome Stättner, S.
 2013
 45 S3 p. S255-
1 p.
 artikel
43 OP-12 Results of surgical management of cholangiocarcinoma of the extrahepatic bile ducts Frena, A.
 2013
 45 S3 p. S252-
1 p.
 artikel
44 OP-08 Results of transarterial chemoembolisation using a low-embolic technique in patients with intermediate stage hepatocellular carcinoma Rodt, T.
 2013
 45 S3 p. S251-
1 p.
 artikel
45 OP-03 α-Santalol demonstrates antitumor and antiantiangiogenic activities in models of hepatocellular carcinoma in vitro and in vivo Saraswati, S.
 2013
 45 S3 p. S249-S250
2 p.
 artikel
46 OP-11 Serum C-reactive protein (CRP) as biomarker for overall survival in patients with sorafenib therapy with hepatocellular carcinoma Koch, S.
 2013
 45 S3 p. S252-
1 p.
 artikel
47 OP-18 Simultaneous laparoscopic resection of colorectal cancer and liver metastasis. Case report and question: Who should do it? Dokić, M.
 2013
 45 S3 p. S254-
1 p.
 artikel
48 OP-33 STAT6 in the anti-proliferative activities of type I interferon: The roles of SP1 and BCL6 Hsu, Y.-A.
 2013
 45 S3 p. S259-S260
2 p.
 artikel
49 OP-31 The Nd:YAG LIMAX® 120 high-output laser: local effects and resection capacity on liver parenchyma Kirschbaum, A.
 2013
 45 S3 p. S259-
1 p.
 artikel
50 OP-35 The role of FDG PET-CT in the preoperative work up of colorectal liver metastasis Al Ali, C.
 2013
 45 S3 p. S260-
1 p.
 artikel
51 OP-34 Ultrasound imaging of colorectal liver metastasis: Still relevant or already outdated? Al Ali, C.
 2013
 45 S3 p. S260-
1 p.
 artikel
52 SAT-08 Closing remarks Spatz, H.
 2013
 45 S3 p. S248-
1 p.
 artikel
53 SAT-07 Combination of SIRT with systemic therapies: Where are we now? Wasan, H.S.
 2013
 45 S3 p. S248-
1 p.
 artikel
54 SAT-06 Combination of TACE with systemic therapies: Where are we now? Martin, R.C.G.
 2013
 45 S3 p. S247-S248
2 p.
 artikel
55 SAT-05 Hepatic arterial therapy (HAI) for the treatment of colorectal liver metastases Kemeny, N.
 2013
 45 S3 p. S247-
1 p.
 artikel
56 SAT-03 Neoadjuvant treatment of liver metastases Köhne, C.-H.
 2013
 45 S3 p. S247-
1 p.
 artikel
57 SAT-04 Radiation lobectomy vs PVE in HCC Salem, R.
 2013
 45 S3 p. S247-
1 p.
 artikel
58 SAT-01 Resection of colorectal liver metastases Poston, G.J.
 2013
 45 S3 p. S246-
1 p.
 artikel
59 SAT-02 Resection or ablation Prevoo, W.
 2013
 45 S3 p. S247-
1 p.
 artikel
60 THU-03 Angiogenesis inhibition in cancer Carmeliet, P.
 2013
 45 S3 p. S234-
1 p.
 artikel
61 THU-12 Combination of liver directed therapies with systemic therapies Bruix, J.
 2013
 45 S3 p. S238-S239
2 p.
 artikel
62 THU-05 Does size matter in embolotherapy? Orsi, F.
 2013
 45 S3 p. S234-S235
2 p.
 artikel
63 THU-06 Does size matter in local ablation? Crocetti, L.
 2013
 45 S3 p. S235-S236
2 p.
 artikel
64 THU-17 Endoscopic treatment options for cholangiocarcinomas Mönkemüller, K.
 2013
 45 S3 p. S240-
1 p.
 artikel
65 THU-09 Hepatocellular carcinoma downstaging to transplantation Toso, C.
 2013
 45 S3 p. S237-
1 p.
 artikel
66 THU-11 Hepatocellular carcinoma – Intraarterial therapies: SIRT or TACE Jakobs, T.F.
 2013
 45 S3 p. S238-
1 p.
 artikel
67 THU-10 Hepatocellular carcinoma: Resection or ablation Rhim, H.
 2013
 45 S3 p. S237-S238
2 p.
 artikel
68 THU-07 Imaging follow-up after liver-directed therapies: Which method, which response criteria? Lencioni, R.
 2013
 45 S3 p. S236-
1 p.
 artikel
69 THU-15 Intraarterial therapies: SIRT or TACE Helmberger, T.
 2013
 45 S3 p. S239-S240
2 p.
 artikel
70 THU-01 Liver directed therapies: Are we changing prognosis? Wilke, H.
 2013
 45 S3 p. S233-
1 p.
 artikel
71 THU-02 Liver metastases of colorectal cancer: Is there a specific molecular signature? Seufferlein, T.
 2013
 45 S3 p. S233-S234
2 p.
 artikel
72 THU-14 Liver resection for intrahepatic cholangiocarcinoma – Single center experience with 49 resections in 64 patients over a 4-year period Baumgart, J.
 2013
 45 S3 p. S239-
1 p.
 artikel
73 THU-08 Molecular signature of prognosis and outcomes in hepatocellular carcinoma Llovet, J.M.
 2013
 45 S3 p. S236-S237
2 p.
 artikel
74 THU-04 Rationale for intraarterial therapies of liver malignancies Geschwind, J.F.
 2013
 45 S3 p. S234-
1 p.
 artikel
75 THU-16 Systemic therapies for cholangiocarcinoma: State of the art 2013 Zhu, A.X.
 2013
 45 S3 p. S240-
1 p.
 artikel
76 THU-13 Systemic therapy for HCC: State-of-art Poon, R.T.
 2013
 45 S3 p. S239-
1 p.
 artikel
                             76 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland